OMRF co-leading national extra dose COVID-19 vaccine trial in people with autoimmune disease

The National Institutes of Health has named the Oklahoma Medical Research Foundation one of the lead sites for a nationwide COVID-19 vaccine clinical trial. The study will assess the antibody response to an extra vaccine dose in people living with certain autoimmune diseases who did not respond well to an original COVID-19 vaccine regimen. OMRF Vice President of Clinical Affairs and Arthritis…